SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of Report (date of earliest event reported): June 13, 2012



                                 BIOCUREX, INC.
                       ----------------------------------
                 (Name of Small Business Issuer in its charter)

     Texas                              0-26947                  75-2742601
----------------------------     ------------------         ------------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
of incorporation)                                           Identification No.)


                           7080 River Road, Suite 215
                   Richmond, British Columbia , Canada V6X 1X5
                ------------------------------------------------
          (Address of Principal Executive Offices, including Zip Code)


       Registrant's telephone number, including area code: (866) 884-8669




                                       N/A
                   ------------------------------------------
          (Former name or former address if changed since last report)




<PAGE>


Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
            Appointment of Certain Officer; Compensatory Arrangements of Certain
            Officers.

     On June 13, 2012, Mr. Trent Davis, President of Paulson Investment Company,
Inc. ("PIC"),  resigned as a director of the Company. Mr. Davis' resignation was
not due to any  disagreement  with the  Company  on any matter  relating  to the
Company's operations,  policies or practices.  Instead, given the possibility of
strategic transactions between PIC and the Company, Mr. Davis determined that it
was in the best  interests  of PIC for him to resign as a  Company  director  in
order to eliminate the potential of any conflicting affiliations between PIC and
the Company, including with respect to a $150,000 loan by PIC to the Company.

                                       2

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date: June 18, 2012

                                     BIOCUREX, INC.


                                     By:/s/ Ricardo Moro
                                        -------------------------------------
                                        Dr. Ricardo Moro, President


                                       3

<PAGE>
[{"type": "8-K", "sequence": "1", "filename": "form8kdavisresign6-12.txt", "description": "FORM 8-K RE DAVIS RESIGN", "secsgml_size_bytes": 2842}]
{"company-data": {"conformed-name": "BIOCUREX INC", "cik": "0001092562", "assigned-sic": "3841", "irs-number": "752742601", "state-of-incorporation": "A1", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26947", "film-number": "12914780"}, "business-address": {"street1": "7080 RIVER RD", "street2": "STE 215", "city": "RICHMOND", "state": "A1", "zip": "V6X 1X5", "phone": "6042079150"}, "mail-address": {"street1": "7080 RIVER RD", "street2": "STE 215", "city": "RICHMOND", "state": "A1", "zip": "V6X 1X5"}, "former-company": {"former-conformed-name": "WHISPERING OAKS INTERNATIONAL INC", "date-changed": "19990804"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): June 13, 2012

                                 BIOCUREX, INC.
                       ----------------------------------
                 (Name of Small Business Issuer in its charter)

     Texas                              0-26947                  75-2742601
----------------------------     ------------------         ------------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
of incorporation)                                           Identification No.)

                           7080 River Road, Suite 215
                   Richmond, British Columbia , Canada V6X 1X5
                ------------------------------------------------
          (Address of Principal Executive Offices, including Zip Code)

       Registrant's telephone number, including area code: (866) 884-8669

                                       N/A
                   ------------------------------------------
          (Former name or former address if changed since last report)
Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
            Appointment of Certain Officer; Compensatory Arrangements of Certain
            Officers.

     On June 13, 2012, Mr. Trent Davis, President of Paulson Investment Company,
Inc. ("PIC"),  resigned as a director of the Company. Mr. Davis' resignation was
not due to any  disagreement  with the  Company  on any matter  relating  to the
Company's operations,  policies or practices.  Instead, given the possibility of
strategic transactions between PIC and the Company, Mr. Davis determined that it
was in the best  interests  of PIC for him to resign as a  Company  director  in
order to eliminate the potential of any conflicting affiliations between PIC and
the Company, including with respect to a $150,000 loan by PIC to the Company.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: June 18, 2012

                                     BIOCUREX, INC.

                                     By:/s/ Ricardo Moro
                                        -------------------------------------
                                        Dr. Ricardo Moro, President

                                       3